RMR vs. AMEH, ICFI, ASTH, HURN, MEG, HCKT, BWMN, III, JUNE, and LICN
Should you be buying The RMR Group stock or one of its competitors? The main competitors of The RMR Group include Apollo Medical (AMEH), ICF International (ICFI), Astrana Health (ASTH), Huron Consulting Group (HURN), Montrose Environmental Group (MEG), The Hackett Group (HCKT), Bowman Consulting Group (BWMN), Information Services Group (III), Junee (JUNE), and Lichen China (LICN). These companies are all part of the "management consulting services" industry.
The RMR Group (NASDAQ:RMR) and Apollo Medical (NASDAQ:AMEH) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, community ranking, media sentiment, valuation and risk.
The RMR Group presently has a consensus price target of $32.00, suggesting a potential upside of 38.89%. Apollo Medical has a consensus price target of $47.20, suggesting a potential upside of 15.63%. Given The RMR Group's higher probable upside, equities research analysts plainly believe The RMR Group is more favorable than Apollo Medical.
The RMR Group received 211 more outperform votes than Apollo Medical when rated by MarketBeat users. However, 60.79% of users gave Apollo Medical an outperform vote while only 60.38% of users gave The RMR Group an outperform vote.
In the previous week, The RMR Group had 1 more articles in the media than Apollo Medical. MarketBeat recorded 1 mentions for The RMR Group and 0 mentions for Apollo Medical. The RMR Group's average media sentiment score of 1.36 beat Apollo Medical's score of 0.88 indicating that The RMR Group is being referred to more favorably in the media.
The RMR Group has a net margin of 4.59% compared to Apollo Medical's net margin of 3.56%. Apollo Medical's return on equity of 9.90% beat The RMR Group's return on equity.
The RMR Group has higher earnings, but lower revenue than Apollo Medical. The RMR Group is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.
42.3% of The RMR Group shares are owned by institutional investors. Comparatively, 35.9% of Apollo Medical shares are owned by institutional investors. 54.9% of The RMR Group shares are owned by company insiders. Comparatively, 8.5% of Apollo Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
The RMR Group has a beta of 1.24, suggesting that its share price is 24% more volatile than the S&P 500. Comparatively, Apollo Medical has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500.
Summary
The RMR Group beats Apollo Medical on 10 of the 18 factors compared between the two stocks.
Get The RMR Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for RMR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RMR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The RMR Group Competitors List
Related Companies and Tools
